Insights from the Construction of Adenovirus-Based Vaccine Candidates against SARS-CoV-2: Expecting the Unexpected.
| dc.rights.license | open | en_US |
| dc.contributor.author | WEKLAK, Denice | |
| dc.contributor.author | TISBORN, Julian | |
| dc.contributor.author | MANGOLD, Maurin Helen | |
| dc.contributor.author | SCHEU, Raphael | |
| hal.structure.identifier | Microbiologie Fondamentale et Pathogénicité [MFP] | |
| dc.contributor.author | WODRICH, Harald | |
| dc.contributor.author | HAGEDORN, Claudia | |
| dc.contributor.author | JÖNSSON, Franziska | |
| dc.contributor.author | KREPPEL, Florian | |
| dc.date.accessioned | 2024-10-07T10:51:41Z | |
| dc.date.available | 2024-10-07T10:51:41Z | |
| dc.date.issued | 2023-10-25 | |
| dc.identifier.issn | 1999-4915 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/202287 | |
| dc.description.abstractEn | To contain the spread of the SARS-CoV-2 pandemic, rapid development of vaccines was required in 2020. Rational design, international efforts, and a lot of hard work yielded the market approval of novel SARS-CoV-2 vaccines based on diverse platforms such as mRNA or adenovirus vectors. The great success of these technologies, in fact, contributed significantly to control the pandemic. Consequently, most scientific literature available in the public domain discloses the results of clinical trials and reveals data of efficaciousness. However, a description of processes and rationales that led to specific vaccine design is only partially available, in particular for adenovirus vectors, even though it could prove helpful for future developments. Here, we disclose our insights from the endeavors to design compatible functional adenoviral vector platform expression cassettes for the SARS-CoV-2 spike protein. We observed that contextualizing genes from an ssRNA virus into a DNA virus provides significant challenges. Besides affecting physical titers, expression cassette design of adenoviral vaccine candidates can affect viral propagation and spike protein expression. Splicing of mRNAs was affected, and fusogenicity of the spike protein in ACE2-overexpressing cells was enhanced when the ER retention signal was deleted. | |
| dc.language.iso | EN | en_US |
| dc.subject.en | Humans | |
| dc.subject.en | Adenovirus Vaccines | |
| dc.subject.en | COVID-19 | |
| dc.subject.en | COVID-19 Vaccines | |
| dc.subject.en | SARS-CoV-2 | |
| dc.subject.en | Spike Glycoprotein | |
| dc.subject.en | Coronavirus | |
| dc.subject.en | RNA | |
| dc.subject.en | Messenger | |
| dc.subject.en | Adenoviridae | |
| dc.title.en | Insights from the Construction of Adenovirus-Based Vaccine Candidates against SARS-CoV-2: Expecting the Unexpected. | |
| dc.title.alternative | Viruses | en_US |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.3390/v15112155 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Microbiologie et Parasitologie | en_US |
| dc.identifier.pubmed | 38005833 | en_US |
| bordeaux.journal | Viruses | en_US |
| bordeaux.volume | 15 | en_US |
| bordeaux.hal.laboratories | MFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234 | en_US |
| bordeaux.issue | 11 | en_US |
| bordeaux.institution | Bordeaux INP | en_US |
| bordeaux.institution | CNRS | |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| bordeaux.import.source | pubmed | |
| hal.identifier | hal-04723761 | |
| hal.version | 1 | |
| hal.date.transferred | 2024-10-07T10:51:43Z | |
| hal.popular | non | en_US |
| hal.audience | Internationale | en_US |
| hal.export | true | |
| workflow.import.source | pubmed | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Viruses&rft.date=2023-10-25&rft.volume=15&rft.issue=11&rft.eissn=1999-4915&rft.issn=1999-4915&rft.au=WEKLAK,%20Denice&TISBORN,%20Julian&MANGOLD,%20Maurin%20Helen&SCHEU,%20Raphael&WODRICH,%20Harald&rft.genre=article |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||